C12Y 102/01036
Retinal dehydrogenase
Official title: Retinal dehydrogenase (1.2.1.36)
C12Y102/01036 (Retinal dehydrogenase) appears on 4 US grants and 11 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 11
- Assignees
- 7
- Inventors
- 28
- Latest grant
- 15 Apr 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 1 | 2 |
| 2019 | 0 | 0 |
| 2020 | 1 | 1 |
| 2021 | 0 | 1 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
| 2026 | 0 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Method for utilizing engineered dendritic cells to induce gut-homing regulatory T cells and treat gut inflammation15 Apr 2025US 12,275,961 B2Loma Linda University
- Methods and compositions for red-shifted chromophore substitution for optogenetic applications31 May 2022US 11,344,630 B2Washington University
- Method for utilizing engineered dendritic cells to induce gut-homing regulatory T cells and treat gut inflammation3 Mar 2020US 10,577,669 B2Loma Linda University
- Methods and compositions for red-shifted chromophore substitution for optogenetic applications14 Aug 2018US 10,047,130 B2Washington University
- Combinations of retinaldehyde dehydrogenase 1 (raldh1) inhibitors and immunostimulators and methods using same27 Aug 2026US 2026/0248799 A1Government of the United States of America, represented by the Secretary, Department of Health
- Biomimetic torpedo for stent-free and targeted gene therapy to prevent restenosis1 Jan 2026US 2026/0000619 A1
- Uses of modified rna encoding retinaldehyde dehydrogenase6 Nov 2025US 2025/0339458 A1President and Fellows of Harvard College
- Uses of modified rna encoding retinaldehyde dehydrogenase4 Nov 2021US 2021/0338709 A1President and Fellows of Harvard College
- Method for utilizing engineered dendritic cells to induce gut-homing regulatory t cells and treat gut inflammation14 May 2020US 2020/0149121 A1Loma Linda University
Most cited
By later US patents